Allaying considerations about any enhance in costs of medicines, Well being Minister Mansukh Mandaviya on Monday stated the federal government has not effected any hike and only some important medicine which might be linked to the wholesale worth index and are as such priced very low may even see some automated rise or fall as per inflation traits.
“There are some important medicines linked to WPI that may see rise or fall robotically as per the WPI motion. These are medicine which might be priced a number of rupees and subsequently, a ten per cent WPI enhance might result in the worth rising by a number of paise,” Mandaviya stated.
The federal government has no position within the worth of those medicines and it has not effected any enhance in costs and it has no plans to take action, he stated.
The costs of those medicines additionally robotically decline when WPI falls, Mandaviya instructed reporters right here.
Issues have been raised in some quarters after the drug pricing authority NPPA lately allowed a worth hike for scheduled medicine, that are beneath worth management beneath the Nationwide Checklist of Important Medicines (NLEM), with impact from April.
These medicine embrace paracetamol, antibiotics used to deal with bacterial infections, anti-anaemia, nutritional vitamins and minerals.
Additionally Learn: CCI orders probe into Zomato, Swiggy biz models
Additionally Learn: Over 800 essential medicines, including Paracetamol, to get expensive from April